Cargando…
Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial
234 diagnostic formalin-fixed paraffin-embedded (FFPE) blocks from homogeneously treated patients with locally advanced head and neck squamous cell carcinoma (HNSCC) within a multicentre phase III clinical trial were characterised. The mutational spectrum was examined by next generation sequencing i...
Autores principales: | Fernández-Mateos, Javier, Pérez-García, Jéssica, Seijas-Tamayo, Raquel, Mesía, Ricard, Rubió-Casadevall, Jordi, García-Girón, Carlos, Iglesias, Lara, Carral Maseda, Alberto, Adansa Klain, Juan Carlos, Taberna, Miren, Vazquez, Silvia, Gómez, María Asunción, del Barco, Edel, Ocana, Alberto, González-Sarmiento, Rogelio, Cruz-Hernández, Juan Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539152/ https://www.ncbi.nlm.nih.gov/pubmed/33024167 http://dx.doi.org/10.1038/s41598-020-72927-2 |
Ejemplares similares
-
Genetic Susceptibility in Head and Neck Squamous Cell Carcinoma in a Spanish Population
por: Fernández-Mateos, Javier, et al.
Publicado: (2019) -
Analysis of autophagy gene polymorphisms in Spanish patients with head and neck squamous cell carcinoma
por: Fernández-Mateos, Javier, et al.
Publicado: (2017) -
Cetuximab-Containing Combinations in Locally Advanced and Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Taberna, Miren, et al.
Publicado: (2019) -
SEOM-TTCC clinical guideline in nasopharynx cancer (2021)
por: Rueda Domínguez, Antonio, et al.
Publicado: (2022) -
TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neck
por: Rubió-Casadevall, Jordi, et al.
Publicado: (2023)